Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 245

1.

C-reactive protein (CRP) promotes malignant properties in pancreatic neuroendocrine neoplasms.

Schimmack S, Yang Y, Felix K, Herbst M, Li Y, Schenk M, Bergmann F, Hackert T, Strobel O.

Endocr Connect. 2019 Jun 1. pii: EC-19-0132.R2. doi: 10.1530/EC-19-0132. [Epub ahead of print]

2.

Standardized endocystectomy technique for surgical treatment of uncomplicated hepatic cystic echinococcosis.

Al-Saeedi M, Khajeh E, Hoffmann K, Ghamarnejad O, Stojkovic M, Weber TF, Golriz M, Strobel O, Junghanss T, Büchler MW, Mehrabi A.

PLoS Negl Trop Dis. 2019 Jun 21;13(6):e0007516. doi: 10.1371/journal.pntd.0007516. [Epub ahead of print]

3.

Abdominal drainage versus no drainage after distal pancreatectomy: study protocol for a randomized controlled trial.

Kaiser J, Niesen W, Probst P, Bruckner T, Doerr-Harim C, Strobel O, Knebel P, Diener MK, Mihaljevic AL, Büchler MW, Hackert T.

Trials. 2019 Jun 7;20(1):332. doi: 10.1186/s13063-019-3442-0.

4.

[Acute cholecystitis in high-risk patients : Laparoscopic cholecystectomy or interventional drainage?]

Strobel O, Büchler MW.

Chirurg. 2019 May 16. doi: 10.1007/s00104-019-0980-7. [Epub ahead of print] German. No abstract available.

PMID:
31098653
5.

[Laparoscopic pancreatoduodenectomy: risk without benefits?]

Strobel O, Büchler MW.

Chirurg. 2019 Jun;90(6):503. doi: 10.1007/s00104-019-0974-5. German. No abstract available.

PMID:
31065768
6.

Laparoscopic Versus Open Pancreaticoduodenectomy: A Systematic Review and Meta-analysis of Randomized Controlled Trials.

Nickel F, Haney CM, Kowalewski KF, Probst P, Limen EF, Kalkum E, Diener MK, Strobel O, Müller-Stich BP, Hackert T.

Ann Surg. 2019 Apr 8. doi: 10.1097/SLA.0000000000003309. [Epub ahead of print]

PMID:
30973388
7.

Prognostic Factors of Survival After Neoadjuvant Treatment and Resection for Initially Unresectable Pancreatic Cancer.

Klaiber U, Schnaidt ES, Hinz U, Gaida MM, Heger U, Hank T, Strobel O, Neoptolemos JP, Mihaljevic AL, Büchler MW, Hackert T.

Ann Surg. 2019 Mar 20. doi: 10.1097/SLA.0000000000003270. [Epub ahead of print]

PMID:
30921051
8.

Chemotherapy for pancreatic cancer.

Springfeld C, Jäger D, Büchler MW, Strobel O, Hackert T, Palmer DH, Neoptolemos JP.

Presse Med. 2019 Mar;48(3 Pt 2):e159-e174. doi: 10.1016/j.lpm.2019.02.025. Epub 2019 Mar 15. Review.

PMID:
30879894
9.

[Endoscopic or percutaneous preoperative biliary drainage for Klatskin tumors].

Strobel O, Büchler MW.

Chirurg. 2019 Mar;90(3):240. doi: 10.1007/s00104-019-0923-3. German. No abstract available.

PMID:
30806713
10.

[No superiority of mattress versus conventional interrupted sutures for pancreaticojejunostomy].

Strobel O, Büchler MW.

Chirurg. 2019 Mar;90(Suppl 2):63. doi: 10.1007/s00104-019-0900-x. German. No abstract available.

PMID:
30758632
11.

[mFOLFIRINOX for adjuvant therapy of pancreatic cancer].

Strobel O, Büchler MW.

Chirurg. 2019 Mar;90(Suppl 2):59. doi: 10.1007/s00104-019-0912-6. German. No abstract available.

PMID:
30758631
12.

[Volume therapy in major visceral surgical interventions].

Strobel O, Büchler MW.

Chirurg. 2019 Mar;90(Suppl 2):119. doi: 10.1007/s00104-019-0896-2. German. No abstract available.

PMID:
30758618
13.

[Postoperative pancreatic fistula : Update of definition and grading].

Strobel O, Büchler MW.

Chirurg. 2019 Mar;90(Suppl 2):89. doi: 10.1007/s00104-019-0829-0. German. No abstract available.

PMID:
30758607
14.

[A nomogram for the prediction of malignancy in branch-duct IPMN].

Strobel O, Büchler MW.

Chirurg. 2019 Mar;90(Suppl 2):92. doi: 10.1007/s00104-019-0822-7. German. No abstract available.

PMID:
30758601
15.

[Meta-analysis of induction of hypertrophy in two-stage hepatectomy].

Strobel O, Büchler MW.

Chirurg. 2019 Mar;90(Suppl 2):90. doi: 10.1007/s00104-019-0827-2. German. No abstract available.

PMID:
30758594
16.

[Gemcitabine and capecitabine as new standard of care for adjuvant therapy in pancreatic cancer].

Strobel O, Büchler MW.

Chirurg. 2019 Mar;90(Suppl 2):86. doi: 10.1007/s00104-019-0842-3. German. No abstract available.

PMID:
30758585
17.

[Neoadjuvant therapy vs. upfront resection for resectable pancreatic cancer].

Strobel O, Büchler MW.

Chirurg. 2019 Mar;90(Suppl 2):85. doi: 10.1007/s00104-019-0844-1. German. No abstract available.

PMID:
30758584
18.

[Perihilar cholangiocarcinoma Bismuth type IV: Resection frequently possible].

Strobel O, Büchler MW.

Chirurg. 2019 Mar;90(Suppl 2):84. doi: 10.1007/s00104-019-0849-9. German. No abstract available.

PMID:
30758580
19.

[Unresectable colorectal liver metastases : Prolonged survival with aggressive local therapy].

Strobel O, Büchler MW.

Chirurg. 2019 Mar;90(Suppl 2):81. doi: 10.1007/s00104-019-0854-z. German. No abstract available.

PMID:
30758571
20.

[Treatment effect of liver resection vs. RFA or TACE in hepatocellular carcinoma].

Strobel O, Büchler MW.

Chirurg. 2019 Mar;90(Suppl 2):75. doi: 10.1007/s00104-019-0868-6. German. No abstract available.

PMID:
30758564
21.

[Pancreatoduodenectomy vs duodenum-preserving pancreatic head resection for chronic pancreatitis].

Strobel O, Büchler MW.

Chirurg. 2019 Mar;90(Suppl 2):77. doi: 10.1007/s00104-019-0865-9. German. No abstract available.

PMID:
30758563
22.

[Branch duct IPMN: resection or surveillance?]

Strobel O, Büchler MW.

Chirurg. 2019 Mar;90(Suppl 2):74. doi: 10.1007/s00104-019-0871-y. German. No abstract available.

PMID:
30758560
23.

[Unresectable intrahepatic cholangiocarcinoma: 50 % resectability after neoadjuvant therapy].

Strobel O, Büchler MW.

Chirurg. 2019 Mar;90(Suppl 2):70. doi: 10.1007/s00104-019-0875-7. German. No abstract available.

PMID:
30758552
24.

[Artery-first approach for partial pancreatoduodenectomy].

Strobel O, Büchler MW.

Chirurg. 2019 Mar;90(Suppl 2):67. doi: 10.1007/s00104-019-0891-7. German. No abstract available.

PMID:
30758544
25.

[Ethanol injection for ablation of persistent bile leaks].

Strobel O, Büchler MW.

Chirurg. 2019 Mar;90(Suppl 2):66. doi: 10.1007/s00104-019-0892-6. German. No abstract available.

PMID:
30758543
26.

Systematic Generation of Patient-Derived Tumor Models in Pancreatic Cancer.

Ehrenberg KR, Gao J, Oppel F, Frank S, Kang N, Dieter SM, Herbst F, Möhrmann L, Dubash TD, Schulz ER, Strakerjahn H, Giessler KM, Weber S, Oberlack A, Rief EM, Strobel O, Bergmann F, Lasitschka F, Weitz J, Glimm H, Ball CR.

Cells. 2019 Feb 10;8(2). pii: E142. doi: 10.3390/cells8020142.

27.

Laparoscopic pancreatoduodenectomy: safety concerns and no benefits.

Strobel O, Büchler MW.

Lancet Gastroenterol Hepatol. 2019 Mar;4(3):186-187. doi: 10.1016/S2468-1253(19)30006-8. Epub 2019 Jan 24. No abstract available. Erratum in: Lancet Gastroenterol Hepatol. 2019 Mar;4(3):e2.

PMID:
30685488
28.

Germline BRCA2 K3326X and CHEK2 I157T mutations increase risk for sporadic pancreatic ductal adenocarcinoma.

Obazee O, Archibugi L, Andriulli A, Soucek P, Małecka-Panas E, Ivanauskas A, Johnson T, Gazouli M, Pausch T, Lawlor RT, Cavestro GM, Milanetto AC, Di Leo M, Pasquali C, Hegyi P, Szentesi A, Radu CE, Gheorghe C, Theodoropoulos GE, Bergmann F, Brenner H, Vodickova L, Katzke V, Campa D, Strobel O, Kaiser J, Pezzilli R, Federici F, Mohelnikova-Duchonova B, Boggi U, Lemstrova R, Johansen JS, Bojesen SE, Chen I, Jensen BV, Capurso G, Pazienza V, Dervenis C, Sperti C, Mambrini A, Hackert T, Kaaks R, Basso D, Talar-Wojnarowska R, Maiello E, Izbicki JR, Cuk K, Saum KU, Cantore M, Kupcinskas J, Palmieri O, Delle Fave G, Landi S, Salvia R, Fogar P, Vashist YK, Scarpa A, Vodicka P, Tjaden C, Iskierka-Jazdzewska E, Canzian F.

Int J Cancer. 2019 Aug 1;145(3):686-693. doi: 10.1002/ijc.32127. Epub 2019 Feb 7.

PMID:
30672594
29.

Randomized Trial of Pylorus-Preserving vs. Pylorus-Resecting Pancreatoduodenectomy: Long-Term Morbidity and Quality of Life.

Klaiber U, Probst P, Hüttner FJ, Bruckner T, Strobel O, Diener MK, Mihaljevic AL, Büchler MW, Hackert T.

J Gastrointest Surg. 2019 Jan 22. doi: 10.1007/s11605-018-04102-y. [Epub ahead of print]

PMID:
30671796
30.

[Necrotizing pancreatitis : Long-term outcomes show superiority of the step-up approach versus open necrosectomy].

Strobel O, Büchler MW.

Chirurg. 2019 Feb;90(2):153. doi: 10.1007/s00104-019-0791-x. German. No abstract available.

PMID:
30656398
31.

[Spindle and giant cell type undifferentiated carcinoma of the distal bile duct: a case report].

Albrecht T, Mehrabi A, Strobel O, Vogel MN, Stenzinger A, Bergmann F, Schirmacher P, Goeppert B.

Z Gastroenterol. 2019 Jan;57(1):52-56. doi: 10.1055/a-0784-8763. Epub 2019 Jan 14. German.

PMID:
30641603
32.

Genetic variability of the ABCC2 gene and clinical outcomes in pancreatic cancer patients.

Gentiluomo M, Puchalt García P, Galeotti AA, Talar-Wojnarowska R, Tjaden C, Tavano F, Strobel O, Kupcinskas J, Neoptolemos J, Hegyi P, Costello E, Pezzilli R, Sperti C, Lawlor RT, Capurso G, Szentesi A, Soucek P, Vodicka P, Lovecek M, Hackert T, Cavestro GM, Milanetto AC, Canzian F, Campa D.

Carcinogenesis. 2019 Jun 10;40(4):544-550. doi: 10.1093/carcin/bgz006.

PMID:
30629142
33.

[Perioperative outcomes of minimally invasive versus open pancreatoduodenectomy].

Strobel O, Büchler MW.

Chirurg. 2019 Jan;90(1):64. doi: 10.1007/s00104-018-0789-9. German. No abstract available.

PMID:
30610258
34.

Agnostic Pathway/Gene Set Analysis of Genome-Wide Association Data Identifies Associations for Pancreatic Cancer.

Walsh N, Zhang H, Hyland PL, Yang Q, Mocci E, Zhang M, Childs EJ, Collins I, Wang Z, Arslan AA, Beane-Freeman L, Bracci PM, Brennan P, Canzian F, Duell EJ, Gallinger S, Giles GG, Goggins M, Goodman GE, Goodman PJ, Hung RJ, Kooperberg C, Kurtz RC, Malats N, LeMarchand L, Neale RE, Olson SH, Scelo G, Shu XO, Van Den Eeden SK, Visvanathan K, White E, Zheng W; PanScan and PanC4 consortia, Albanes D, Andreotti G, Babic A, Bamlet WR, Berndt SI, Borgida A, Boutron-Ruault MC, Brais L, Brennan P, Bueno-de-Mesquita B, Buring J, Chaffee KG, Chanock S, Cleary S, Cotterchio M, Foretova L, Fuchs C, M Gaziano JM, Giovannucci E, Goggins M, Hackert T, Haiman C, Hartge P, Hasan M, Helzlsouer KJ, Herman J, Holcatova I, Holly EA, Hoover R, Hung RJ, Janout V, Klein EA, Kurtz RC, Laheru D, Lee IM, Lu L, Malats N, Mannisto S, Milne RL, Oberg AL, Orlow I, Patel AV, Peters U, Porta M, Real FX, Rothman N, Sesso HD, Severi G, Silverman D, Strobel O, Sund M, Thornquist MD, Tobias GS, Wactawski-Wende J, Wareham N, Weiderpass E, Wentzensen N, Wheeler W, Yu H, Zeleniuch-Jacquotte A, Kraft P, Li D, Jacobs EJ, Petersen GM, Wolpin BM, Risch HA, Amundadottir LT, Yu K, Klein AP, Stolzenberg-Solomon RZ.

J Natl Cancer Inst. 2018 Dec 12. doi: 10.1093/jnci/djy155. [Epub ahead of print]

35.

Neoadjuvant and adjuvant chemotherapy in pancreatic cancer.

Klaiber U, Leonhardt CS, Strobel O, Tjaden C, Hackert T, Neoptolemos JP.

Langenbecks Arch Surg. 2018 Dec;403(8):917-932. doi: 10.1007/s00423-018-1724-8. Epub 2018 Nov 5. Review.

PMID:
30397779
36.

Dexamethasone-induced inhibition of miR-132 via methylation promotes TGF-β-driven progression of pancreatic cancer.

Abukiwan A, Nwaeburu CC, Bauer N, Zhao Z, Liu L, Gladkich J, Gross W, Benner A, Strobel O, Fellenberg J, Herr I.

Int J Oncol. 2019 Jan;54(1):53-64. doi: 10.3892/ijo.2018.4616. Epub 2018 Nov 1.

37.

[mFOLFIRINOX for adjuvant therapy of pancreatic cancer].

Strobel O, Büchler MW.

Chirurg. 2018 Dec;89(12):1007. doi: 10.1007/s00104-018-0759-2. German. No abstract available.

PMID:
30357431
38.

Optimizing the outcomes of pancreatic cancer surgery.

Strobel O, Neoptolemos J, Jäger D, Büchler MW.

Nat Rev Clin Oncol. 2019 Jan;16(1):11-26. doi: 10.1038/s41571-018-0112-1. Review.

PMID:
30341417
39.

Genetic determinants of telomere length and risk of pancreatic cancer: A PANDoRA study.

Campa D, Matarazzi M, Greenhalf W, Bijlsma M, Saum KU, Pasquali C, van Laarhoven H, Szentesi A, Federici F, Vodicka P, Funel N, Pezzilli R, Bueno-de-Mesquita HB, Vodickova L, Basso D, Obazee O, Hackert T, Soucek P, Cuk K, Kaiser J, Sperti C, Lovecek M, Capurso G, Mohelnikova-Duchonova B, Khaw KT, König AK, Kupcinskas J, Kaaks R, Bambi F, Archibugi L, Mambrini A, Cavestro GM, Landi S, Hegyi P, Izbicki JR, Gioffreda D, Zambon CF, Tavano F, Talar-Wojnarowska R, Jamroziak K, Key TJ, Fave GD, Strobel O, Jonaitis L, Andriulli A, Lawlor RT, Pirozzi F, Katzke V, Valsuani C, Vashist YK, Brenner H, Canzian F.

Int J Cancer. 2019 Mar 15;144(6):1275-1283. doi: 10.1002/ijc.31928. Epub 2018 Nov 12.

PMID:
30325019
40.

Impact of Surgeon's Experience on Vascular and Haemorrhagic Complications After Kidney Transplantation.

Kulu Y, Fathi P, Golriz M, Khajeh E, Sabagh M, Ghamarnejad O, Mieth M, Ulrich A, Hackert T, Müller-Stich BP, Strobel O, Michalski C, Morath C, Zeier M, Büchler MW, Mehrabi A.

Eur J Vasc Endovasc Surg. 2019 Jan;57(1):139-149. doi: 10.1016/j.ejvs.2018.07.041. Epub 2018 Sep 17.

PMID:
30236441
41.

Postoperative pancreatic fistula: Microbial growth determines outcome.

Loos M, Strobel O, Legominski M, Dietrich M, Hinz U, Brenner T, Heininger A, Weigand MA, Büchler MW, Hackert T.

Surgery. 2018 Dec;164(6):1185-1190. doi: 10.1016/j.surg.2018.07.024. Epub 2018 Sep 11.

PMID:
30217397
42.

[Resection strategies for adrenocortical carcinoma].

Schimmack S, Strobel O.

Chirurg. 2019 Jan;90(1):9-14. doi: 10.1007/s00104-018-0712-4. Review. German.

PMID:
30159583
43.

[No superiority of mattress versus conventional interrupted sutures for pancreaticojejunostomy].

Strobel O, Büchler MW.

Chirurg. 2018 Sep;89(9):734. doi: 10.1007/s00104-018-0692-4. German. No abstract available.

PMID:
30027393
44.

Definition of an extended minimum level of lymphadenectomy in non-pancreatic periampullary cancer resections.

Liu B, Heckler M, Heger U, Roth S, Klaiber U, Büchler MW, Strobel O, Michalski CW, Hackert T.

HPB (Oxford). 2018 Nov;20(11):1028-1033. doi: 10.1016/j.hpb.2018.05.002. Epub 2018 Jun 19.

PMID:
29929786
45.

[Volume therapy in major visceral surgical interventions].

Strobel O, Büchler MW.

Chirurg. 2018 Aug;89(8):639. doi: 10.1007/s00104-018-0675-5. German. No abstract available.

PMID:
29922988
46.

Common genetic variants associated with pancreatic adenocarcinoma may also modify risk of pancreatic neuroendocrine neoplasms.

Obazee O, Capurso G, Tavano F, Archibugi L, De Bonis A, Greenhalf W, Key T, Pasquali C, Milanetto AC, Hackert T, Fogar P, Lico V, Dervenis C, Lawlor RT, Landoni L, Gazouli M, Zambon CF, Funel N, Strobel O, Jamroziak K, Cantu C, Malecka-Panas E, Landi S, Neoptolemos JP, Basso D, Talar-Wojnarowska R, Rinzivillo M, Andriulli A, Canzian F, Campa D.

Carcinogenesis. 2018 Jul 3;39(7):969. doi: 10.1093/carcin/bgy067. No abstract available.

PMID:
29868886
47.

NRG1 Fusions in KRAS Wild-Type Pancreatic Cancer.

Heining C, Horak P, Uhrig S, Codo PL, Klink B, Hutter B, Fröhlich M, Bonekamp D, Richter D, Steiger K, Penzel R, Endris V, Ehrenberg KR, Frank S, Kleinheinz K, Toprak UH, Schlesner M, Mandal R, Schulz L, Lambertz H, Fetscher S, Bitzer M, Malek NP, Horger M, Giese NA, Strobel O, Hackert T, Springfeld C, Feuerbach L, Bergmann F, Schröck E, von Kalle C, Weichert W, Scholl C, Ball CR, Stenzinger A, Brors B, Fröhling S, Glimm H.

Cancer Discov. 2018 Sep;8(9):1087-1095. doi: 10.1158/2159-8290.CD-18-0036. Epub 2018 May 25.

PMID:
29802158
48.

[Artery-first approach for partial pancreatoduodenectomy].

Strobel O, Büchler MW.

Chirurg. 2018 Jun;89(6):481. doi: 10.1007/s00104-018-0651-0. German. No abstract available.

PMID:
29766212
49.

[Ethanol injection for ablation of persistent bile leaks].

Strobel O, Büchler MW.

Chirurg. 2018 Jul;89(7):560. doi: 10.1007/s00104-018-0652-z. German. No abstract available.

PMID:
29766211
50.

Validation of at least 1 mm as cut-off for resection margins for pancreatic adenocarcinoma of the body and tail.

Hank T, Hinz U, Tarantino I, Kaiser J, Niesen W, Bergmann F, Hackert T, Büchler MW, Strobel O.

Br J Surg. 2018 Aug;105(9):1171-1181. doi: 10.1002/bjs.10842. Epub 2018 May 8.

PMID:
29738626

Supplemental Content

Loading ...
Support Center